Granahan Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Granahan Investment Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-250,826	Closed	-$4.01M	–	209
2018 Q4	$4.01M	Buy	250,826 +232,841	+1,295%	+$5.12M	0.28%	90
2018 Q3	$595K	Buy	17,985 +34	+0.2%	+$874	0.03%	187
2018 Q2	$406K	Buy	17,951 +2,513	+16%	+$59.6K	0.02%	191
2018 Q1	$448K	Buy	15,438 +1,747	+13%	+$51.1K	0.03%	187
2017 Q4	$382K	Buy	+13,691	New	+$425K	0.03%	190
2015 Q4	–	Sell	-65,655	Closed	-$794K	–	255
2015 Q3	$794K	Sell	65,655 -2,810	-4%	-$40.6K	0.02%	245
2015 Q2	$1.19M	Hold	68,465	–	–	0.03%	230
2015 Q1	$993K	Buy	68,465 +820	+1%	+$8.96K	0.03%	226
2014 Q4	$568K	Hold	67,645	–	–	0.02%	208
2014 Q3	$751K	Hold	67,645	–	–	0.02%	205
2014 Q2	$1.24M	Hold	67,645	–	–	0.04%	207
2014 Q1	$1.01M	Buy	67,645 +20,180	+43%	+$362K	0.03%	203
2013 Q4	$869K	Hold	47,465	–	–	0.02%	207
2013 Q3	$978K	Hold	47,465	–	–	0.03%	207
2013 Q2	$1.19M	Buy	+47,465	New	+$2.03M	0.03%	214

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

EWM

Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Granahan Investment Management's AVEO Position: Q1 2019 in Review

Granahan Investment Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2019, closing a stake of 250,826 shares — an estimated $4.01M sold.

Granahan Investment Management first reported a position in AVEO in Q2 2013 and held it in 15 quarters. The position peaked at $4.01M in Q4 2018. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

Granahan Investment Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Granahan Investment Management sold 250,826 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $4.01M.
Granahan Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 15 quarters.
Granahan Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $4.01M in Q4 2018.
83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on Granahan Investment Management's 13F filing for Q1 2019, filed 14 May 2019.